Orin Green Financial’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.3K | Sell |
10,000
-54,433
| -84% | -$115K | 0.01% | 82 |
|
|
2026
Q1 | $140K | Buy |
64,433
+3,000
| +5% | +$7.45K | 0.06% | 75 |
|
|
2025
Q4 | $111K | Buy |
61,433
+233
| +0.4% | +$476 | 0.04% | 73 |
|
|
2025
Q3 | $136K | Hold |
61,200
| – | – | 0.05% | 83 |
|
|
2025
Q2 | $90.6K | Buy |
61,200
+11,200
| +22% | +$22.9K | 0.04% | 76 |
|
|
2025
Q1 | $128K | Buy |
+50,000
| New | +$119K | 0.06% | 72 |
|
|
2024
Q4 | – | Sell |
-72,000
| Closed | -$102K | – | 75 |
|
|
2024
Q3 | $73.4K | Hold |
72,000
| – | – | 0.03% | 80 |
|
|
2024
Q2 | $84.2K | Buy |
+72,000
| New | +$85.1K | 0.04% | 74 |
|
|
2024
Q1 | – | Sell |
-80,000
| Closed | -$119K | – | 76 |
|
|
2023
Q4 | $142K | Hold |
80,000
| – | – | 0.07% | 74 |
|
|
2023
Q3 | $133K | Buy |
80,000
+19,850
| +33% | +$35.6K | 0.07% | 67 |
|
|
2023
Q2 | $120K | Buy |
+60,150
| New | +$143K | 0.06% | 67 |
|